BACKGROUND: Most patients managed in primary care have more than one condition. Multimorbidity presents challenges for the patient and the clinician, not only in terms of the process of care, but also in terms of management and risk assessment. AIM: To examine the effect of the presence of chronic kidney disease and diabetes on mortality and morbidity among patients with established cardiovascular disease. DESIGN OF STUDY: Retrospective cohort study. SETTING: Random selection of 35 general practices in the west of Ireland. METHOD: A practice-based sample of 1609 patients with established cardiovascular disease was generated in 2000-2001 and followed for 5 years. The primary endpoint was death from any cause and the secondary endpoint was a cardiovascular composite endpoint that included death from a cardiovascular cause or any of the following cardiovascular events: myocardial infarction, heart failure, peripheral vascular disease, or stroke. RESULTS: Risk of death from any cause was significantly increased in patients with increased multimorbidity (P<0.001), as was the risk of the cardiovascular composite endpoint (P<0.001). Patients with cardiovascular disease and diabetes had a similar survival pattern to those with cardiovascular disease and chronic kidney disease, but experienced more cardiovascular events. CONCLUSION: Level of multimorbidity is an independent predictor of prognosis among patients with established cardiovascular disease. In such patients, the presence of chronic kidney disease carries a similar mortality risk to diabetes. Multimorbidity may be a useful factor in prioritising management of patients in the community with significant cardiovascular risk.
BACKGROUND: Most patients managed in primary care have more than one condition. Multimorbidity presents challenges for the patient and the clinician, not only in terms of the process of care, but also in terms of management and risk assessment. AIM: To examine the effect of the presence of chronic kidney disease and diabetes on mortality and morbidity among patients with established cardiovascular disease. DESIGN OF STUDY: Retrospective cohort study. SETTING: Random selection of 35 general practices in the west of Ireland. METHOD: A practice-based sample of 1609 patients with established cardiovascular disease was generated in 2000-2001 and followed for 5 years. The primary endpoint was death from any cause and the secondary endpoint was a cardiovascular composite endpoint that included death from a cardiovascular cause or any of the following cardiovascular events: myocardial infarction, heart failure, peripheral vascular disease, or stroke. RESULTS: Risk of death from any cause was significantly increased in patients with increased multimorbidity (P<0.001), as was the risk of the cardiovascular composite endpoint (P<0.001). Patients with cardiovascular disease and diabetes had a similar survival pattern to those with cardiovascular disease and chronic kidney disease, but experienced more cardiovascular events. CONCLUSION: Level of multimorbidity is an independent predictor of prognosis among patients with established cardiovascular disease. In such patients, the presence of chronic kidney disease carries a similar mortality risk to diabetes. Multimorbidity may be a useful factor in prioritising management of patients in the community with significant cardiovascular risk.
Authors: Nagesh S Anavekar; John J V McMurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer Journal: N Engl J Med Date: 2004-09-23 Impact factor: 91.245
Authors: Liam G Glynn; Donal Reddan; John Newell; John Hinde; Brian Buckley; Andrew W Murphy Journal: Nephrol Dial Transplant Date: 2007-04-23 Impact factor: 5.992
Authors: R Scott Wright; Guy S Reeder; Charles A Herzog; Robert C Albright; Brent A Williams; David L Dvorak; Wayne L Miller; Joseph G Murphy; Stephen L Kopecky; Allan S Jaffe Journal: Ann Intern Med Date: 2002-10-01 Impact factor: 25.391
Authors: Michael G Shlipak; Paul A Heidenreich; Haruko Noguchi; Glenn M Chertow; Warren S Browner; Mark B McClellan Journal: Ann Intern Med Date: 2002-10-01 Impact factor: 25.391
Authors: Jassim Al Suwaidi; Donal N Reddan; Kathryn Williams; Karen S Pieper; Robert A Harrington; Robert M Califf; Christopher B Granger; E Magnus Ohman; David R Holmes Journal: Circulation Date: 2002-08-20 Impact factor: 29.690
Authors: Shannon M Dunlay; Margaret M Redfield; Ruoxiang Jiang; Susan A Weston; Véronique L Roger Journal: Circ Heart Fail Date: 2015-04-01 Impact factor: 8.790
Authors: Cynthia M Boyd; Bruce Leff; Jennifer L Wolff; Qilu Yu; Jing Zhou; Cynthia Rand; Carlos O Weiss Journal: J Am Geriatr Soc Date: 2011-05 Impact factor: 5.562
Authors: Laura M McCann; Sharon L Haughey; Carole Parsons; Fran Lloyd; Grainne Crealey; Gerard J Gormley; Carmel M Hughes Journal: Health Expect Date: 2012-10-15 Impact factor: 3.377
Authors: Simon de Lusignan; Hugh Gallagher; Tom Chan; Nicki Thomas; Jeremy van Vlymen; Michael Nation; Neerja Jain; Aumran Tahir; Elizabeth du Bois; Iain Crinson; Nigel Hague; Fiona Reid; Kevin Harris Journal: Implement Sci Date: 2009-07-14 Impact factor: 7.327
Authors: Jocelyn Anderson; Liam G Glynn; John Newell; Alberto A Iglesias; Donal Reddan; Andrew W Murphy Journal: BMC Cardiovasc Disord Date: 2009-11-12 Impact factor: 2.298